Comment on

• Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort.

  Schnitzler F, Fidder H, Ferrante M, Noman M, Arijs I, Van Assche G, Hoffman I, Van Steen K, Vermeire S, Rutgeerts P. Schnitzler F, et al. Gut. 2009 Apr;58(4):492-500. doi: 10.1136/gut.2008.155812. Epub 2008 Oct 2. Gut. 2009. PMID: 18832518 Clinical Trial.
• Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study.

  Fidder H, Schnitzler F, Ferrante M, Noman M, Katsanos K, Segaert S, Henckaerts L, Van Assche G, Vermeire S, Rutgeerts P. Fidder H, et al. Gut. 2009 Apr;58(4):501-8. doi: 10.1136/gut.2008.163642. Epub 2008 Oct 2. Gut. 2009. PMID: 18832524